The Japanese Biochemical Society/The Molecular Biology Society of Japan

9:02 AM - 9:13 AM

[4W6-1] Studies on the development of a novel anticancer drug targeting NAD+ biosynthetic key enzyme, nicotinamide phosphoribosyltransferase

〇Akira Sato1, Yoko Ogino1, Yuri Shibasaki1, Kiyotaka Katsuragi1, Atsushi Yoshimori2, Takahiro Oyama3, Hideaki Abe3, Sei-chi Tanuma1,4 (1.Dept. of Biochem., Fac. of Pharm. Sci., Tokyo Univ. of Sci., 2.Inst. for Theoretical Med., Inc., 3.Hinoki Shinyaku Co., Ltd, 4.Genome & Drug Res. Ctr., Tokyo Univ. of Sci.)

NAD+-poly(ADP-ribose) metabolism, NAD+ biosynthesis, NAMPT, NAMPT inhibitor

This archive has moved to the member page of The Molecular Biology Society of Japan and The Japanese Biochemical Society.
Members of the either society can access the abstracts via links at the member page of the sites.
Please feel free to contact the journal offices for any inquiries.

Password